Armon Sharei
Net worth: - $ as of 31/05/2026
Net worth: - $ as of 31/05/2026
Armon R.
Sharei was the founder of SQZ Biotechnologies Co. (2013), holding the title of President, Chief Executive Officer & Director.
Dr. Sharei is the founder of Portal Biotechnologies Inc. (2023), holding the title of President, CEO, Secretary, Treasurer & Director.
Dr. Sharei is currently the Chief Executive Officer at Sqz Biotechnologies, Inc. Dr. Sharei is currently an Independent Director at Genenta Science SpA, starting in 2024.
Dr. Sharei's education includes an undergraduate degree from Stanford University and a doctorate from the Massachusetts Institute of Technology.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
GENENTA SCIENCE SPA -.--% | 30/03/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Companies | Position | Start |
|---|---|---|
| GENENTA SCIENCE S.P.A. | Director/Board Member | 02/05/2024 |
Sqz Biotechnologies, Inc. | Chief Executive Officer | - |
| Companies | Position | End |
|---|---|---|
| SQZ BIOTECHNOLOGIES COMPANY | Chief Executive Officer | 30/11/2022 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 5 |
|---|---|
SQZ Biotechnologies Co.
SQZ Biotechnologies Co. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops cell therapies for patients with cancer, infectious diseases and serious conditions | Health Technology |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Massachusetts Institute of Technology
Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Genenta Science SpA
Genenta Science SpA Pharmaceuticals: MajorHealth Technology Develops gene transfer therapy for the treatment of cancer tumors | Health Technology |
Sqz Biotechnologies, Inc. |
Select your edition
All financial news and data tailored to specific country editions